Published in Blood Weekly, November 29th, 2007
"The overall response rate of extensive metabolizers (EMs) was statistically higher than that of poor metabolizers (PMs) (62.6% vs. 33.3%, p< 0.05). Similar results were also observed in the Thal+Dex cohort," wrote Y. Li and colleagues.
The researchers concluded: "For the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.